Please provide your email address to receive an email when new articles are posted on . SCAI has released a consensus statement on management of the technical aspects of PCI for patients with STEMI.

Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

The American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with other societies, released a full guideline on the management of patients with ACS on Thursday, ...

WASHINGTON —The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred ...

Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved in ...

SAN DIEGO, CA — Is informed consent necessary to randomize patients with ST-segment elevation MI (STEMI) into clinical trials? That was the question two experts grappled with this week at the Society ...

The presence of shock or respiratory failure did not prolong D2B times in patients using the Rampart system. The Rampart ...